Case number 2016-2302
Gilead Sciences, Inc. v. Merck & Co., Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | GILEAD SCIENCES, INC. v. MERCK & CO., INC. [OPINION] [precedential] (0) |
| Apr 23, 2021 | 0 | GILEAD SCIENCES, INC. v. MERCK & CO., INC. [ERRATA] [precedential] (0) |
| Jan 7, 2019 | 106 | The petition for writ of certiorari, [18-378], filed on 09/21/2018, was Denied on 01/07/2019. [576533] [JAB] [Entered: 01/08/2019 08:13 AM] (1) |
| Oct 17, 2018 | 105 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [103], certificate of interest Docket No. [104], ERROR: The amended entry of appearance and amended certificate of interest were filed in a closed case. CORRECTION: As this case is closed and the mandate has issued, no action will be taken on these documents. [558182] [JAB] [Entered: 10/17/2018 03:32 PM] (0) |
| Oct 15, 2018 | 103 | Amended Entry of appearance for Stephen S. Rabinowitz as of counsel for Appellants Merck & Co., Inc., Merck Sharp & Dohme Corp. and Isis Pharmaceuticals, Inc.. Service: 10/15/2018 by email. [557297] [16-2302] [Stephen Rabinowitz] [Entered: 10/15/2018 06:34 PM] (2) |
| Oct 15, 2018 | 104 | Amended Certificate of Interest for the Appellants Merck & Co., Inc., Merck Sharp & Dohme Corp. and Isis Pharmaceuticals, Inc.. Service: 10/15/2018 by email. [557298] [16-2302] [Stephen Rabinowitz] [Entered: 10/15/2018 06:36 PM] (4) |
| Sep 25, 2018 | 102 | Petition for writ of Certiorari filed on 09/21/2018, and placed on the docket 09/24/2018, in the Supreme Court of the United States. Supreme Court #: 18-378, Merck & Co., Inc., et al. v. Gilead Sciences, Inc. [552496] [JAB] [Entered: 09/25/2018 03:42 PM] (1) |
| Jul 23, 2018 | 101 | Notice from the Supreme Court of the United States: The application for an extension of time within which to file a petition for a writ of certiorari in the above-entitled case has been presented to the Chief Justice, who on July 16, 2018, extended the time to and including September 21, 2018. [538365] [JAB] [Entered: 07/25/2018 08:55 AM] (3) |
| Jun 1, 2018 | 100 | Mandate issued to the United States District Court for the Northern District of California. Service as of this date by the Clerk of Court. [526073] [16-2302, 16-2615] [SJ] [Entered: 06/01/2018 08:48 AM] (2) |
| May 25, 2018 | 99 | ORDER filed granting motion to extend time to apply for attorney fees [98] filed by Cross-Appellant Gilead Sciences, Inc. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [524815] [SJ] [Entered: 05/25/2018 03:32 PM] (2) |
| May 24, 2018 | 98 | MOTION of Cross-Appellant Gilead Sciences, Inc. Extend time to apply for Attorney Fees under Federal Circuit Rule 47.7 [Consent: unopposed]. Service: 05/24/2018 by email. [524556] [16-2302] [Elizabeth Flanagan] [Entered: 05/24/2018 07:25 PM] (6) |
| Apr 26, 2018 | 97 | ERRATUM to the Precedential Opinion Doc No.: [96]. Service as of this date by the Clerk of Court. [517016] [16-2302, 16-2615] [JAB] [Entered: 04/26/2018 10:14 AM] (1) |
| Apr 25, 2018 | 96 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Taranto, Circuit Judge; Clevenger, Circuit Judge and Chen, Circuit Judge). [516667] [16-2302, 16-2615] [SJ] [Entered: 04/25/2018 09:16 AM] (34) |
| Feb 5, 2018 | 95 | Submitted after ORAL ARGUMENT by Jeffrey A. Lamken for Merck & Co., Inc., Merck Sharp & Dohme Corp. and Isis Pharmaceuticals, Inc. and Juanita Rose Brooks for Gilead Sciences, Inc. Panel: Judge: Taranto, Judge: Clevenger, Judge: Chen. [495056] [SJ] [Entered: 02/05/2018 11:03 AM] (0) |
| Jan 16, 2018 | 93 | Response to oral argument order from the Cross-Appellant Gilead Sciences, Inc.. designating Juanita R. Brooks as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [489692] [Juanita Brooks] [Entered: 01/16/2018 11:51 AM] (0) |
| Jan 16, 2018 | 94 | Response to oral argument order from the Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. designating Jeffrey A. Lamken as arguing attorney. Designated time for argument: 9 minutes. Designated time for rebuttal: 6 minutes. Service of other counsel by Notice of Docket Activity from this entry. [489840] [Jeffrey Lamken] [Entered: 01/16/2018 03:39 PM] (0) |
| Dec 19, 2017 | 92 | NOTICE OF CALENDARING. Panel: 1802C. Case scheduled Feb 05, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 01/16/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [483795] [JAB] [Entered: 12/19/2017 01:52 PM] (0) |
| Nov 28, 2017 | 91 | Notice from Cross-Appellant Gilead Sciences, Inc. regarding conflicts with oral argument (February 12, 2018 and March 5-7, 2018). Service: 11/28/2017 by email. [478648] [Juanita Brooks] [Entered: 11/28/2017 02:39 PM] (2) |
| Nov 13, 2017 | 89 | MOTION of Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. to withdraw counsel Sanjiv Prakash Laud. Any response is due within 10 days of service [Consent: unopposed]. Service: 11/10/2017 by email. [474532] [Sanjiv Laud] [Entered: 11/10/2017 09:43 AM] (5) |
| Nov 13, 2017 | 90 | **TEXT ONLY** ORDER granting motion to withdraw attorney [89] filed by Appellants Merck & Co., Inc., Merck Sharp & Dohme Corp. and Isis Pharmaceuticals, Inc. Sanjiv P. Laud is withdrawn as counsel for Appellants. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [474590] [MJL] [Entered: 11/13/2017 08:25 AM] (0) |
| Oct 20, 2017 | 88 | Notice from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. regarding conflicts with oral argument (November 6-9, 2017; December 7, 2017; January 11-12, 2018). Service: 10/20/2017 by email. [469517] [Jeffrey Lamken] [Entered: 10/20/2017 02:52 PM] (1) |
| Sep 5, 2017 | 87 | Notice from Cross-Appellant Gilead Sciences, Inc. regarding conflicts with oral argument (January 11, 2018). Service: 09/05/2017 by email. [458526] [Juanita Brooks] [Entered: 09/05/2017 11:36 AM] (1) |
| Sep 1, 2017 | 86 | Notice from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. regarding conflicts with oral argument (November 6-9, 2017, and January 11-12, 2018). Service: 09/01/2017 by email. [458173] [Jeffrey Lamken] [Entered: 09/01/2017 09:04 AM] (1) |
| Aug 30, 2017 | 85 | 6 paper copies of the Corrected Joint Appendix (Vols. I- VI) [83] received from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. [457798] [CW] [Entered: 08/30/2017 03:43 PM] (0) |
| Aug 29, 2017 | 84 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [NOV, DEC, JAN], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 09/05/2017. [457294] [MJL] [Entered: 08/29/2017 10:42 AM] (0) |
| Aug 24, 2017 | 82 | RESPONSE of Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. to the supplemental authority [75] filed by Cross-Appellant Gilead Sciences, Inc. in 16-2302. Service: 08/24/2017 by email. [456283] [Jeffrey Lamken] [Entered: 08/24/2017 08:53 AM] (3) |
| Aug 23, 2017 | 80 | Notice of Correction to the Brief Doc No. [76] for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 08/23/2017 by email. [456201] [Jeffrey Lamken] [Entered: 08/23/2017 04:14 PM] (3) |
| Aug 23, 2017 | 81 | TENDERED from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Title: CORRECTED JOINT APPENDIX. Service: 08/23/2017 by email. [456208] [Jeffrey Lamken] [Entered: 08/23/2017 04:24 PM] (3886) |
| Aug 23, 2017 | 83 | CORRECTED APPENDIX FILED for Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. [81]. Number of Pages: 3886. Service: 08/23/2017 by email. The paper copies of the appendix should be received by the court on or before 09/01/2017. [456530] [MJL] [Entered: 08/25/2017 08:39 AM] (3886) |
| Aug 21, 2017 | 76 | TENDERED from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Title: JOINT APPENDIX. Service: 08/21/2017 by email. [455345]. This appendix has been corrected. See Doc. No. [83]. [Jeffrey Lamken] [Entered: 08/21/2017 12:18 PM] (0) |
| Aug 21, 2017 | 77 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc., Merck Sharp & Dohme Corp. and Cross-Appellant Gilead Sciences, Inc.. Service: 08/21/2017 by email. [455347] [Jeffrey Lamken] [Entered: 08/21/2017 12:21 PM] (4) |
| Aug 21, 2017 | 78 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 08/21/2017 by email. [455349] [Jeffrey Lamken] [Entered: 08/21/2017 12:24 PM] (3) |
| Aug 21, 2017 | 79 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellant Gilead Sciences, Inc.. Service: 08/21/2017 by email. [455555] [Deanna Reichel] [Entered: 08/21/2017 05:08 PM] (4) |
| Aug 18, 2017 | 75 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Cross-Appellant Gilead Sciences, Inc.. Service: 08/18/2017 by email. [455066] [Jonathan Singer] [Entered: 08/18/2017 11:24 AM] (12) |
| Aug 16, 2017 | 74 | 6 paper copies of the Reply Brief [73] received from Cross-Appellant Gilead Sciences, Inc. [454291] [CW] [Entered: 08/16/2017 10:39 AM] (0) |
| Aug 14, 2017 | 72 | TENDERED from Cross-Appellant Gilead Sciences, Inc.. Title: REPLY BRIEF. Service: 08/14/2017 by email. [453894] [Jonathan Singer] [Entered: 08/14/2017 08:01 PM] (36) |
| Aug 14, 2017 | 73 | REPLY BRIEF FILED for Cross-Appellant Gilead Sciences, Inc. [72]. Number of Pages: 29. Service: 08/14/2017 by email. The paper copies of the brief should be received by the court on or before 08/22/2017. Appendix is due 08/21/2017. [453994] [MJL] [Entered: 08/15/2017 10:31 AM] (36) |
| Aug 11, 2017 | 71 | **TEXT ONLY** ORDER granting motion to withdraw attorney [70] filed by Cross-Appellant Gilead Sciences, Inc. Rachel Wainer Apter is withdrawn as counsel for Cross-Appellant. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [453185] [MJL] [Entered: 08/11/2017 08:11 AM] (0) |
| Aug 10, 2017 | 70 | MOTION of Cross-Appellant Gilead Sciences, Inc. to withdraw counsel Rachel Wainer Apter. Any response is due within 10 days of service [Consent: unopposed]. Service: 08/10/2017 by email. [453170] [Rachel Apter] [Entered: 08/10/2017 05:46 PM] (3) |
| Jul 6, 2017 | 66 | MOTION of Cross-Appellant Gilead Sciences, Inc. to extend the time to 08/14/2017 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/06/2017 by email. [444390] [Deanna Reichel] [Entered: 07/06/2017 09:45 AM] (7) |
| Jul 6, 2017 | 67 | Notice of Rejection to Cross-Appellant Gilead Sciences, Inc., the following document is REJECTED for filing: motion to extend time to file reply brief [66]. Reason: incorrect relief. Service: 07/06/2017 by clerk. [444393] [MJL] [Entered: 07/06/2017 09:50 AM] (1) |
| Jul 6, 2017 | 68 | MOTION of Cross-Appellant Gilead Sciences, Inc. to extend the time to 08/14/2017 to file the cross-appellant's reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/06/2017 by email. [444445] [Deanna Reichel] [Entered: 07/06/2017 11:40 AM] (7) |
| Jul 6, 2017 | 69 | **TEXT ONLY** ORDER granting motion to extend time to file cross-appellant's reply brief [68] filed by Cross-Appellant Gilead Sciences, Inc. The brief is due 08/14/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [444448] [MJL] [Entered: 07/06/2017 11:43 AM] (0) |
| Jul 5, 2017 | 65 | 6 paper copies of the Reply Brief [64] received from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. [444154] [CW] [Entered: 07/05/2017 12:41 PM] (0) |
| Jun 30, 2017 | 63 | TENDERED from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Title: REPLY BRIEF. Service: 06/30/2017 by email. [443541] [Jeffrey Lamken] [Entered: 06/30/2017 02:30 PM] (79) |
| Jun 30, 2017 | 64 | REPLY BRIEF FILED for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. [63]. Number of Pages: 66. Service: 06/30/2017 by email. The paper copies of the brief should be received by the court on or before 07/11/2017. Cross-Appellant's reply brief is due 07/14/2017. [443787] [MJL] [Entered: 07/03/2017 09:37 AM] (79) |
| Apr 18, 2017 | 60 | MOTION of Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. to extend time until 06/30/2017 at 11:59 pm to file (Appellants' Cross-Appeal Response and Reply Brief.). [Consent: unopposed]. Service: 04/18/2017 by email. [425099] [Jeffrey Lamken] [Entered: 04/18/2017 01:31 PM] (12) |
| Apr 18, 2017 | 61 | **TEXT ONLY** ORDER granting motion to extend time to file response and reply brief [60] filed by Appellants Merck & Co., Inc., Merck Sharp & Dohme Corp. and Isis Pharmaceuticals, Inc.. The brief is due 06/30/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [425230] [MJL] [Entered: 04/18/2017 03:44 PM] (0) |
| Apr 18, 2017 | 62 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The motion to extend time [60] filed by appellants selected an incorrect relief. CORRECTION: When requesting an extension of time for an appellant's response and reply brief, the correct relief is "extend time to file reply brief." For future motions, please ensure the correct relief is selected. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [425232] [MJL] [Entered: 04/18/2017 03:46 PM] (0) |
| Mar 29, 2017 | 59 | 6 paper copies of the Response Brief [58] received from Cross-Appellant Gilead Sciences, Inc. [420009] [KW] [Entered: 03/29/2017 02:58 PM] (0) |
| Mar 20, 2017 | 56 | Entry of appearance for Edmund Hirschfeld as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 03/20/2017 by email. [416865] [Edmund Hirschfeld] [Entered: 03/20/2017 10:25 AM] (1) |
| Mar 20, 2017 | 57 | TENDERED from Cross-Appellant Gilead Sciences, Inc.. Title: RESPONSE BRIEF. Service: 03/20/2017 by email. [417190] [Jonathan Singer] [Entered: 03/20/2017 08:01 PM] (85) |
| Mar 20, 2017 | 58 | BRIEF FILED for Cross-Appellant Gilead Sciences, Inc. [57]. Number of Pages: 75. Service: 03/20/2017 by email. The paper copies of the brief should be received by the court on or before 03/29/2017. Appellants' response and reply brief is due 05/01/2017. [417855] [MJL] [Entered: 03/22/2017 11:57 AM] (85) |
| Feb 15, 2017 | 53 | Entry of appearance for E. Joshua Rosenkranz as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 02/15/2017 by email. [407719] [E. Rosenkranz] [Entered: 02/15/2017 12:59 PM] (1) |
| Feb 15, 2017 | 54 | Entry of appearance for Rachel Wainer Apter as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 02/15/2017 by email. [407721] [Rachel Apter] [Entered: 02/15/2017 01:02 PM] (1) |
| Feb 15, 2017 | 55 | Letter from Cross-Appellant Gilead Sciences, Inc. re: formal ethical wall. Service: 02/15/2017 by email. [407722] [E. Rosenkranz] [Entered: 02/15/2017 01:07 PM] (1) |
| Feb 3, 2017 | 51 | MOTION of Cross-Appellant Gilead Sciences, Inc. to extend the time to 03/20/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/03/2017 by email. [404545] [Deanna Reichel] [Entered: 02/03/2017 12:57 PM] (7) |
| Feb 3, 2017 | 52 | ORDER granting motion to extend time to file cross-appellant's principal and response brief [51] filed by Cross-Appellant Gilead Sciences, Inc.. No further extensions should be anticipated. The brief is due 03/20/2017. Service as of this date by Clerk of Court. [404659] [MJL] [Entered: 02/03/2017 03:28 PM] (2) |
| Dec 13, 2016 | 50 | **TEXT ONLY** ORDER granting motion to extend time to file cross-appellant's opening and response brief [49] filed by Cross-Appellant Gilead Sciences, Inc.. The brief is due 03/06/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [390392] [MJL] [Entered: 12/13/2016 10:34 AM] (0) |
| Dec 12, 2016 | 49 | MOTION of Cross-Appellant Gilead Sciences, Inc. to extend the time to 03/06/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/12/2016 by email. [390122] [Deanna Reichel] [Entered: 12/12/2016 02:56 PM] (7) |
| Dec 1, 2016 | 48 | 6 paper copies of the Corrected Opening Brief [47] received from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. [387542] [KW] [Entered: 12/01/2016 01:58 PM] (0) |
| Nov 29, 2016 | 45 | NOTICE OF REJECTION: The Brief for Defendants-Appellants Merck & Co., Merck Sharp & Dohme Corp., and Isis Pharmaceuticals, Inc. [44] is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 12/13/2016. Cross-Appellant Gilead Sciences, Inc.'s brief is due 01/03/2017. Service as of this date by Clerk of Court. [386706] [MJL] [Entered: 11/29/2016 12:12 PM] (2) |
| Nov 29, 2016 | 46 | TENDERED from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Title: CORRECTED OPENING BRIEF. Service: 11/29/2016 by email. [386864] [Jeffrey Lamken] [Entered: 11/29/2016 02:55 PM] (301) |
| Nov 29, 2016 | 47 | CORRECTED BRIEF FILED for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. [46]. Number of Pages: 71. Service: 11/29/2016 by email. The paper copies of the brief should be received by the court on or before 12/05/2016. [387159] [MJL] [Entered: 11/30/2016 01:25 PM] (301) |
| Nov 23, 2016 | 43 | Entry of appearance for Sara E. Margolis as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Service: 11/23/2016 by email. [385900] [Sara Margolis] [Entered: 11/23/2016 01:54 PM] (2) |
| Nov 23, 2016 | 44 | TENDERED from Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp.. Title: OPENING BRIEF. Service: 11/23/2016 by email. [386049]. This brief has been rejected. See Doc. No. [45]. [Jeffrey Lamken] [Entered: 11/23/2016 07:18 PM] (0) |
| Oct 25, 2016 | 41 | **TEXT ONLY** ORDER granting motion to extend time to file the appellants' opening brief [40] filed by Appellants Merck & Co., Inc., Merck Sharp & Dohme Corp., and Isis Pharmaceuticals, Inc.. The brief is due 11/23/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [377423] [MJL] [Entered: 10/25/2016 11:46 AM] (0) |
| Oct 25, 2016 | 42 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The motion [40] filed by Appellants only includes the case number of the lead appeal on the first page. CORRECTION: For future filings, please ensure the case number for the lead appeal and cross-appeal are included together. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [377425] [MJL] [Entered: 10/25/2016 11:49 AM] (0) |
| Oct 24, 2016 | 40 | MOTION of Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp & Dohme Corp. to extend the time to 11/23/2016 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 11/03/2016 [Consent: unopposed]. Service: 10/24/2016 by email. [377174] [Jeffrey Lamken] [Entered: 10/24/2016 03:38 PM] (10) |
| Oct 4, 2016 | 39 | Official caption revised to correct a typographical error. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [371195] [IW] [Entered: 10/04/2016 10:00 AM] (0) |
| Sep 22, 2016 | 29 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The contact information on the entry of appearance for Jessica Palmer Ryen [26] does not match the contact information in the attorney's user account. CORRECTION: Please update as needed to ensure the contact information on the entry of appearance and in the user account matches. [368516] [MJL] [Entered: 09/22/2016 10:27 AM] (0) |
| Sep 22, 2016 | 30 | NOTICE OF DEFICIENCY: The entry of appearance for Stephen S. Rabinowitz [28] filed by Appellants Merck & Co., Inc., Merck Sharp And Dohme Corp, and Isis Pharmaceuticals, Inc. in 16-2302 is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [368517] [MJL] [Entered: 09/22/2016 10:28 AM] (0) |
| Sep 22, 2016 | 31 | NOTICE OF DEFICIENCY: The entries of appearance for Sarah J. Newman [17], James A. Barta [18], Jeffrey A. Lamken [19], and Michael G. Pattillo, Jr. [20] filed by Appellants Merck & Co., Inc., Merck Sharp And Dohme Corp, and Isis Pharmaceuticals, Inc. in 16-2302 are incomplete and therefore cannot be accepted for filing at this time. All parties counsel is representing must be listed in their entirety on the entry of appearance form; "Et al." is not sufficient. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected documents may be accepted for filing if received before midnight (EST) on the date of this notice. [368520] [MJL] [Entered: 09/22/2016 10:33 AM] (0) |
| Sep 22, 2016 | 32 | Corrected Entry of appearance for Stephen S. Rabinowitz as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/22/2016 by email. [368692] [Stephen Rabinowitz] [Entered: 09/22/2016 04:38 PM] (2) |
| Sep 22, 2016 | 33 | Entry of appearance for Mitchell Epner as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp and Dohme Corp. Service: 09/22/2016 by email. [368694]--[Edited 09/23/2016 by to correct docket text.] [Mitchell Epner] [Entered: 09/22/2016 04:43 PM] (2) |
| Sep 22, 2016 | 34 | Corrected Entry of appearance for Jeffrey A. Lamken as principal counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/22/2016 by email. [368703] [Jeffrey Lamken] [Entered: 09/22/2016 05:33 PM] (2) |
| Sep 22, 2016 | 35 | Amended Certificate of Interest for the Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/22/2016 by email. [368704] [Jeffrey Lamken] [Entered: 09/22/2016 05:34 PM] (3) |
| Sep 22, 2016 | 36 | Corrected Entry of appearance for Michael G. Pattillo, Jr. as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/22/2016 by email. [368705] [Michael Pattillo] [Entered: 09/22/2016 05:36 PM] (2) |
| Sep 22, 2016 | 37 | Corrected Entry of appearance for James A. Barta as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/22/2016 by email. [368706] [James Barta] [Entered: 09/22/2016 05:38 PM] (2) |
| Sep 22, 2016 | 38 | Corrected Entry of appearance for Sarah J. Newman as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/22/2016 by email. [368707] [Sarah Newman] [Entered: 09/22/2016 05:40 PM] (2) |
| Sep 21, 2016 | 8 | Entry of appearance for Craig E. Countryman as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368154] [Craig Countryman] [Entered: 09/21/2016 01:46 PM] (2) |
| Sep 21, 2016 | 9 | Entry of appearance for Juanita R. Brooks as principal counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368157] [Craig Countryman] [Entered: 09/21/2016 01:48 PM] (2) |
| Sep 21, 2016 | 10 | Entry of appearance for Elizabeth M. Flanagan as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368161] [Craig Countryman] [Entered: 09/21/2016 01:50 PM] (2) |
| Sep 21, 2016 | 11 | Entry of appearance for Robert M. Oakes as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368164] [Craig Countryman] [Entered: 09/21/2016 01:52 PM] (2) |
| Sep 21, 2016 | 12 | Entry of appearance for Deanna J. Reichel as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368171] [Craig Countryman] [Entered: 09/21/2016 02:00 PM] (2) |
| Sep 21, 2016 | 13 | Entry of appearance for Jonathan E. Singer as of counsel for Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368173] [Craig Countryman] [Entered: 09/21/2016 02:02 PM] (2) |
| Sep 21, 2016 | 14 | Certificate of Interest for the Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368176] [Craig Countryman] [Entered: 09/21/2016 02:03 PM] (2) |
| Sep 21, 2016 | 15 | Docketing Statement for the Cross-Appellant Gilead Sciences, Inc.. Service: 09/21/2016 by email. [368178] [Craig Countryman] [Entered: 09/21/2016 02:04 PM] (3) |
| Sep 21, 2016 | 16 | This entry was made in error and has been removed from the docket. CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERRROR: Jonathan E. Singer (entry of appearance [13]) is not a registered filer with CM/ECF for the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must be registered for the court's CM/ECF system. Please register promptly. [368276] [MJL] [Entered: 09/21/2016 03:36 PM] (0) |
| Sep 21, 2016 | 17 | Entry of appearance for Sarah J. Newman as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368344] [Sarah Newman] [Entered: 09/21/2016 04:40 PM] (0) |
| Sep 21, 2016 | 18 | Entry of appearance for James A. Barta as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368345] [James Barta] [Entered: 09/21/2016 04:43 PM] (0) |
| Sep 21, 2016 | 19 | Entry of appearance for Jeffrey A. Lamken as principal counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368349] [Jeffrey Lamken] [Entered: 09/21/2016 04:48 PM] (0) |
| Sep 21, 2016 | 20 | Entry of appearance for Michael G. Pattillo, Jr. as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368351] [Michael Pattillo] [Entered: 09/21/2016 04:51 PM] (0) |
| Sep 21, 2016 | 21 | Certificate of Interest for the Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368353] [Jeffrey Lamken] [Entered: 09/21/2016 04:53 PM] (3) |
| Sep 21, 2016 | 22 | Docketing Statement for the Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368354] [Jeffrey Lamken] [Entered: 09/21/2016 04:55 PM] (3) |
| Sep 21, 2016 | 23 | Entry of appearance for Bruce Genderson as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368363] [Bruce Genderson] [Entered: 09/21/2016 05:32 PM] (2) |
| Sep 21, 2016 | 24 | Entry of appearance for Jessamyn S. Berniker as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368364] [Jessamyn Berniker] [Entered: 09/21/2016 05:36 PM] (2) |
| Sep 21, 2016 | 25 | Entry of appearance for Stanley E. Fisher as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368365] [Stanley Fisher] [Entered: 09/21/2016 05:40 PM] (2) |
| Sep 21, 2016 | 26 | Entry of appearance for Jessica Palmer Ryen as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368367] [Jessica Ryen] [Entered: 09/21/2016 05:46 PM] (2) |
| Sep 21, 2016 | 27 | Entry of appearance for Sanjiv Laud as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368373] [Sanjiv Laud] [Entered: 09/21/2016 05:51 PM] (2) |
| Sep 21, 2016 | 28 | Entry of appearance for Stephen S Rabinowitz as of counsel for Appellants Isis Pharmaceuticals, Inc., Merck & Co., Inc. and Merck Sharp And Dohme Corp. Service: 09/21/2016 by email. [368375] [Stephen Rabinowitz] [Entered: 09/21/2016 06:13 PM] (0) |
| Sep 7, 2016 | 4 | ORDER reactivating case. Service as of this date by Clerk of Court. [364776] [MJL] [Entered: 09/07/2016 02:07 PM] (2) |
| Sep 7, 2016 | 5 | Clerk's Note to the File: The parties' entries of appearance, certificates of interest, and docketing statements are due 09/21/2016. [364781] [MJL] [Entered: 09/07/2016 02:17 PM] (0) |
| Sep 7, 2016 | 6 | Note to file: The following cases are consolidated: 16-2302 (Lead) with 16-2615 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [364786] [16-2302, 16-2615] [MJL] [Entered: 09/07/2016 02:29 PM] (0) |
| Sep 7, 2016 | 7 | Official caption revised to reflect cross-appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [364789] [MJL] [Entered: 09/07/2016 02:32 PM] (0) |
| Sep 6, 2016 | 3 | Amended Notice of Appeal for Merck & Co., Inc., Merck Sharp & Dohme Corp., and Isis Pharmaceuticals, Inc.. Service: 09/07/2016 by clerk. [364771] [MJL] [Entered: 09/07/2016 02:04 PM] (83) |
| Jul 7, 2016 | 2 | ORDER deactivating appeal. Service as of this date by Clerk of Court. [349055] [FMS] [Entered: 07/07/2016 12:03 PM] (2) |
| Jul 6, 2016 | 1 | Appeal docketed. Received: 07/05/2016. [348728]Entry of Appearance due 07/20/2016. Certificate of Interest is due on 07/20/2016. Docketing Statement due 07/20/2016. Appellant/Petitioner's brief is due 09/06/2016. [MJL] [Entered: 07/06/2016 12:11 PM] (158) |
